Literature DB >> 2671594

Clinical features and management of poisoning due to phenytoin.

J R Larsen1, L S Larsen.   

Abstract

The widespread use of phenytoin results in frequent accidental and intentional toxicity. Metabolism is enzymatic and can be described by Michaelis-Menten kinetics. This results in an increased half-life in overdose situations and a protracted clinical course which may last a week or more. The primary toxicity is on the central nervous system. The most common initial finding in mild toxicity is nystagmus. As concentrations increase ataxia, decreased coordination, hyper-reflexia, slurred speech and diplopia may develop. Progressive increases result in confusion, lethargy and coma. Various methods tried to increase elimination including dialysis, haemoperfusion, diuresis and plasmaphoresis have been ineffective and are not without risk. Meticulous supportive care including ventilation if necessary should provide a good clinical outcome. Multiple-dose activated charcoal may be helpful in shortening the duration of symptoms.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2671594     DOI: 10.1007/bf03259910

Source DB:  PubMed          Journal:  Med Toxicol Adverse Drug Exp        ISSN: 0113-5244


  125 in total

1.  Rare complication of phenytoin sodium treatment.

Authors:  J T BERGIN; E FISCHER; J V MORRIS
Journal:  Br Med J       Date:  1956-12-29

2.  Seizures and phenytoin toxicity.

Authors:  R M Dasheiff; P Crumrine; G Fromm; C F Terrence
Journal:  Neurology       Date:  1986-10       Impact factor: 9.910

3.  Metabolic effects of phenytoin toxicity.

Authors:  K J Wagner; M Zell; J B Leikin
Journal:  Ann Emerg Med       Date:  1986-04       Impact factor: 5.721

4.  Phenytoin toxicity: a cause of reversible monoplegia.

Authors:  M H Abdulhadi; D D Notman; G C Cardon; P M Johnston
Journal:  Cleve Clin J Med       Date:  1987 Sep-Oct       Impact factor: 2.321

5.  [Hydantoin poisoning: clinical aspects, laboratory parameters and EEG].

Authors:  E Körner; G Ladurner; S Enge; H Lechner
Journal:  Nervenarzt       Date:  1983-10       Impact factor: 1.214

6.  A prolonged severe intoxication after ingestion of phenytoin and phenobarbital.

Authors:  T E Albertson; C J Fisher; T A Shragg; R C Baselt
Journal:  West J Med       Date:  1981-11

7.  Cardiac side effects of phenytoin and carbamazepine. A dose-related phenomenon?

Authors:  L Durelli; R Mutani; G P Sechi; F Monaco; N Glorioso; G Gusmaroli
Journal:  Arch Neurol       Date:  1985-11

8.  Intoxication with 5,5-diphenylhydantoin (Dilantin): clinical features, blood levels, urinary metabolites, and metabolic changes in a child.

Authors:  R Holcomb; R Lynn; B Harvey; B J Sweetman; N Gerber
Journal:  J Pediatr       Date:  1972-04       Impact factor: 4.406

9.  Mucocutaneous lymph node syndrome in an adult receiving diphenylhydantoin.

Authors:  V M Anderson; H M Bauer; A P Kelly
Journal:  Cutis       Date:  1979-04

10.  [Recurrent acute dyskinesia as the sole manifestation of phenytoin poisoning].

Authors:  E Roullet; P Koskas; F Mahieux; R Marteau
Journal:  Rev Neurol (Paris)       Date:  1987       Impact factor: 2.607

View more
  2 in total

1.  The effects of phenytoin on the performance of rats in a delayed match-to-place task.

Authors:  D L Samuelson; L L Arnold; T M Mowery; N A Mesnard; P E Garraghty
Journal:  Integr Physiol Behav Sci       Date:  2005 Jan-Mar

Review 2.  Phenytoin poisoning.

Authors:  Simon Craig
Journal:  Neurocrit Care       Date:  2005       Impact factor: 3.210

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.